PT-141 is a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound functions by enhancing specific receptors across the body, causing to improved sexual response. Clinical studies have suggested that PT-141 may remarkably manage a spectrum of sexual dysfunctions in both men and